IBDEI0T9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13719,0)
 ;;=B97.89^^53^595^89
 ;;^UTILITY(U,$J,358.3,13719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13719,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,13719,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,13719,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,13720,0)
 ;;=B97.10^^53^595^21
 ;;^UTILITY(U,$J,358.3,13720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13720,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,13720,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,13720,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,13721,0)
 ;;=B34.9^^53^595^90
 ;;^UTILITY(U,$J,358.3,13721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13721,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,13721,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,13721,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,13722,0)
 ;;=A69.20^^53^595^50
 ;;^UTILITY(U,$J,358.3,13722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13722,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,13722,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,13722,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,13723,0)
 ;;=A69.22^^53^595^52
 ;;^UTILITY(U,$J,358.3,13723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13723,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,13723,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,13723,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,13724,0)
 ;;=A69.21^^53^595^51
 ;;^UTILITY(U,$J,358.3,13724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13724,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,13724,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,13724,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,13725,0)
 ;;=A69.29^^53^595^18
 ;;^UTILITY(U,$J,358.3,13725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13725,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,13725,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,13725,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,13726,0)
 ;;=A69.23^^53^595^5
 ;;^UTILITY(U,$J,358.3,13726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13726,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,13726,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,13726,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,13727,0)
 ;;=A51.0^^53^595^29
 ;;^UTILITY(U,$J,358.3,13727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13727,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,13727,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,13727,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,13728,0)
 ;;=A52.3^^53^595^54
 ;;^UTILITY(U,$J,358.3,13728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13728,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,13728,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,13728,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,13729,0)
 ;;=A52.10^^53^595^53
 ;;^UTILITY(U,$J,358.3,13729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13729,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,13729,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,13729,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,13730,0)
 ;;=A52.9^^53^595^49
 ;;^UTILITY(U,$J,358.3,13730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13730,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,13730,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,13730,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,13731,0)
 ;;=A53.9^^53^595^79
 ;;^UTILITY(U,$J,358.3,13731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13731,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,13731,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,13731,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,13732,0)
 ;;=B37.3^^53^595^17
 ;;^UTILITY(U,$J,358.3,13732,1,0)
 ;;=^358.31IA^4^2
